Skip to main content
An official website of the United States government
Government Funding Lapse

Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Funded Prevention Grants

PI Name Sort descending PI Organization Title Grant Number Program Official
Kong, Mei

University Of California-Irvine
United States

Using dietary glutamine supplementation for melanoma prevention and targeted therapy 5R01CA244360-05 Gabriela Riscuta, M.D., CNS
Kresty, Laura A

University Of Michigan At Ann Arbor
United States

Developing Natural Products to Target IL-8 Signaling and Intercept Progression of Barrett’s Esophagus to Esophageal Adenocarcinoma 1UG3CA299397-01 Altaf Mohammed, Ph.D.
Kumar, Nagi B.

H. Lee Moffitt Cancer Ctr & Res Inst
United States

Phase II Clinical trial of GTC in Men on Active Surveillance 5R01CA235032-06 Howard L. Parnes, M.D.
Langel, Stephanie N.

Case Western Reserve University
United States

Antibody bound bacteria during HPV infection and cervical dysplasia 3R21CA289927-02S1 Goli Samimi, Ph.D., M.P.H.
Leal, Ana Sofia Mendes

Indiana University Indianapolis
United States

Nrf2, immune cells and lung cancer 7R01CA226690-06 Marjorie Perloff, M.D.
Leslie, Kimberly K.

University Of New Mexico Health Scis Ctr
United States

Advancing Hormone Therapy for Endometrial Cancer 1P01CA278735-01A1 Goli Samimi, Ph.D., M.P.H.
Li, Chi

University Of Louisville
United States

A lung cancer vaccine based on exosomes of induced pluripotent stem cells 1R21CA280453-01 John Clifford, Ph.D.
Li, Bing

University Of Iowa
United States

E-FABP mediates n-3 fatty acid-induced tumor prevention through epigenetic control of immune cell differentiation and function 5R01CA180986-11 Nancy J. Emenaker, Ph.D., RDN, LD, FAND
Li, Yong

Baylor College Of Medicine
United States

Cancer Prevention-Interception Against MGUS Progression 5U54CA272691-03 Anda Vlad, M.D., Ph.D.
Lipkin, Steven M

Weill Medical Coll Of Cornell Univ
United States

CAP-IT Center for LNP RNA Immunoprevention 5U54CA272688-04 John Clifford, Ph.D.
Lu, Junxuan

Pennsylvania State Univ Hershey Med Ctr
United States

Early clinial trials for Angelica herbal supplements for prostate cancer interception 4R01CA260901-04 Gabriela Riscuta, M.D., CNS
Maclean, Paul S.

University Of Colorado Denver
United States

Novel dietary interventions for reducing obesity-associated breast cancer 5R01CA258766-04 Young Kim, Ph.D.
Madeleine, Margaret M

Fred Hutchinson Cancer Center
United States

Colaboracion Evita: HPV-Related Cancer Prevention Partnership Center 3U54CA242977-07S4 Maria Silvina Frech, Ph.D., M.S.
Mallery, Susan R

Ohio State University
United States

Assessment of Chemopreventive Effects of a Mucoadhesive Fenretinide Patch on Premalignant Oral Epithelial Lesions 5R01CA227273-06 Malgorzata Wojtowicz, M.D.
Mallery, Susan R

Ohio State University
United States

Formulation, Evaluation, and Phase 0 Trial of Nanoparticle Releasing Oral Thin Film for OSCC Chemoprevention 5R01CA258757-04 Malgorzata Wojtowicz, M.D.